Fusion Antibodies News

News

Fusion Antibodies to collaborate with Analytics Engines

Fusion Antibodies plc, experts in antibody engineering and Analytics Engines, an advanced data analytics company, have announced a strategic collaboration to incorporate machine learning (ML) and artificial intelligence (AI) into Fusion Antibodies’ CDRx™ humanization platform.
Read more
Fusion Antibodies Supply Antibody Characterization
News

Humanized antibody Jf5 detects Aspergillus

Towards translational ImmunoPET/MR imaging of invasive Pulmonary Aspergillosis: The Humanized Monoclonal Antibody JF5 detects Aspergillus Lung Infections in Vivo
Read more
News

Fusion Antibodies announces partnership with Protein Alternatives

  Fusion Antibodies announces partnership with Protein Alternatives to develop world class humanized antibodies for therapeutic development     Fusion Antibodies plc, a UK-based contract research organisation…
Read more
News

Potential biomarkers for bladder and colon cancer

Non-phosphorylated and Phosphorylated Signal Transduction Peptide (STP) of Tissue Factor (TF) in Urine are Potential Biomarkers for Bladder and Colon Cancer. Objective Tissue factor (TF, CD142) is commonly associated with the initiation…
Read more
News

Funding for Queen’s pancreatic cancer drug research in collaboration with Fusion Antibodies

Queen’s University Belfast researchers at the Centre for Cancer Research and Cell Biology (CCRCB) alongside Fusion Antibodies plc have secured a prestigious Medical Research Council (MRC) award to develop a new antibody drug for the treatment of pancreatic cancer.
Read more
News

Fusion Antibodies to double workforce with help from Invest NI

Fusion Antibodies has announced plans to create 28 new jobs. This recruitment drive, supported by Invest NI, will help Fusion Antibodies deliver its services to its growing international customer base.   Invest NI has offered…
Read more
News

Phase 1 of Fusion Antibodies expansion project underway

We are delighted to showcase the progress of Phase 1 of our ambitious expansion project that is now well underway. As many of you will remember, in December 2017 Fusion Antibodies became one of only three companies in Northern Ireland…
Read more
News

We have made the 2018 NI Dealmakers Awards shortlist!

Fusion Antibodies have been shortlisted for a category at the 2018 Northern Ireland Dealmakers Awards Fusion Antibodies are absolutely delighted to be shortlisted in the Deal of the Year (£2.5m - £10m) award category in the Insider…
Read more
News

Coming in 2018!

We're delighted to announce that we have some new services launching in 2018! Developability and Manufacturability Services! We have developed a range of software analytics delving into the properties of antibodies. These…
Read more
News

Fusion to become third Northern Irish Company listed on the London Stock Exchange

Fusion Antibodies to seek AIM IPO We are delighted to announce that we are seeking a listing on the AIM Market of the London Stock Exchange and has published its AIM Admission Document which will be available to view here. We propose…
Read more
News

Fusion Antibodies are attending PEGS Europe

Fusion Antibodies are pleased to be attending PEGS Europe being held on 13-17th November in Lisbon, Portugal. PEGS Europe is the largest European event covering all aspects of protein and antibody engineering. Last year, in 2016, a record…
Read more
News

Fusion Antibodies are attending BioFIT 2017

Fusion Antibodies are delighted to be attending BioFIT being held on 28-29th November in Strasbourg, France. BioFIT is the leading partnering event in Europe fortechnology transfer, academia-industry collaborations and early-stage…
Read more

Optimize your antibody to be the best

Find out more about partnering with Fusion Antibodies or contact us to start a project

Get Started
JOURNEY WITH US

Discovery
Engineering
Supply

ABOUT US

About Fusion
Our Board
Senior Leadership Team
Scientific Advisory Panel

CONTACT US

info@fusionantibodies.com
+44 (0)28 9043 2800

Investor and Media
+44 (0)20 7933 8780
fusion@walbrookpr.com

Fusion Antibodies PLC, Springbank Industrial Estate, 1 Springbank Rd, Dunmurry, Belfast BT17 0QL